Blue Jays face setback as Max Scherzer’s recovery delayed by back tightness
The Toronto Blue Jays entered the 2025 season with high hopes, bolstered by the signing of veteran pitcher Max Scherzer to a one-year, $15.5 million deal. However, the three-time Cy Young Award winner has been sidelined since his season debut, leaving the team to navigate a challenging season without one of its key acquisitions. As the Blue Jays prepare to host the Tampa Bay Rays for a three-game series at Rogers Centre, fresh concerns about Scherzer’s recovery have surfaced, casting uncertainty over his return. This latest setback underscores the team’s ongoing struggle to stabilize its pitching rotation.
Recent updates indicate Scherzer’s rehabilitation has hit another roadblock, prompting the team to adjust its expectations. The Blue Jays, currently holding a .500 record and sitting third in the American League East, have relied on emerging talents and strategic roster moves to stay competitive. The absence of a pitcher of Scherzer’s caliber, however, has tested the squad’s depth.
- Key challenges: Persistent thumb inflammation and new back tightness.
- Team response: Exploring trade options and leaning on relief pitchers.
- Upcoming series: A chance to capitalize on recent momentum against the Rays.
The organization remains optimistic, but the road ahead requires careful navigation.
Latest setback in Scherzer’s rehab
Max Scherzer’s journey back to the mound took an unexpected turn this week. After a promising bullpen session, the 40-year-old pitcher experienced back tightness, forcing him to skip a scheduled throwing session in Toronto. This development, reported by Mitch Bannon of The Athletic, has altered the Blue Jays’ timeline for Scherzer’s return. The team remains hopeful he can resume throwing soon, but the setback highlights the fragility of his recovery process.
Scherzer has been grappling with right thumb inflammation since his debut on March 29, 2025, against the Baltimore Orioles. In that game, he pitched just three innings, allowing two runs on 45 pitches before exiting due to discomfort. Initially attributed to lat soreness, the issue was later linked to his thumb, a recurring problem that has plagued him in recent seasons. The Blue Jays transferred him to the 60-day injured list on May 5, making him ineligible to return before May 29.
The back tightness adds another layer of complexity. Scherzer, speaking to Sportsnet reporters Hazel Mae and Shi Davidi on May 13, noted similarities to back issues he faced in 2019. He described the sensation as “weird,” occurring during recovery rather than throwing. The team is taking a cautious approach, prioritizing long-term health over a rushed return.
Scherzer’s history of resilience
Max Scherzer’s career is defined by dominance and durability, but injuries have become a recurring theme in recent years. Since 2022, the eight-time All-Star has landed on the injured list seven times, with issues ranging from a teres major strain to a herniated disc requiring surgery in 2023. Despite these challenges, Scherzer has consistently returned to form, posting a 3.95 ERA in nine starts for the Texas Rangers in 2024.
His tenure with the Blue Jays, however, has yet to yield results. Signed to anchor the back of the rotation, Scherzer’s lone start in 2025 ended prematurely. The thumb inflammation, which he described as “giving me all the fits in the world,” required two cortisone injections this season. Manager John Schneider praised Scherzer’s progress during a live batting practice session on May 7, but the recent back tightness has tempered optimism.
- Career highlights: 216-112 record, 3.16 ERA, 3,408 strikeouts.
- Recent struggles: Limited to 17 starts over the past two seasons.
- Current goal: Return by late May to bolster Toronto’s rotation.
Scherzer’s determination to overcome setbacks remains a focal point for the team and its fans.
Blue Jays’ rotation under pressure
The Blue Jays’ pitching staff has faced significant challenges in Scherzer’s absence. Entering their series against the Tampa Bay Rays, Toronto’s starting pitchers ranked 23rd in Major League Baseball with a 4.35 team ERA. The back of the rotation, in particular, has struggled, with right-hander Bowden Francis posting a 5.66 ERA and southpaw Easton Lucas recording a 7.41 ERA in their starts.
To address these gaps, the Blue Jays signed José Ureña and Spencer Turnbull to one-year deals on May 5. Ureña debuted against the Los Angeles Angels, allowing two runs over 4.1 innings, while Turnbull is building up in extended spring camp. These additions provide temporary relief, but the team continues to explore external options, including a potential trade for Pittsburgh Pirates pitcher Mitch Keller, valued at $77 million.
The reliance on relief pitchers has also been notable. Eric Lauer’s 4.2 scoreless innings against the Seattle Mariners on May 10 highlighted the bullpen’s importance. However, the absence of a veteran presence like Scherzer has left the rotation vulnerable, particularly in high-stakes divisional matchups.
Recent success fuels optimism
Despite Scherzer’s absence, the Blue Jays have shown resilience. Their recent 4-2 road trip, capped by a three-game sweep of the Seattle Mariners, brought their record to .500. The final game, a 9-1 rout, featured standout performances from George Springer, who hit a three-run homer, and Addison Barger, who recorded his first home run of the season.
The team’s offensive output has been inconsistent, but contributions from players like Andrés Giménez, who delivered two hits and two RBIs in a recent game, have provided sparks. The Blue Jays rank one game behind the Boston Red Sox for second place in the AL East, with the New York Yankees four games ahead. The upcoming series against the Rays offers a chance to close the gap.
- Road trip highlights: 4-2 record, including a 9-1 win over Seattle.
- Key contributors: Springer, Barger, and Giménez.
- Divisional standing: Third in AL East, chasing Boston and New York.
The Blue Jays are focused on maintaining momentum as they await Scherzer’s return.
Strategic roster adjustments
The Blue Jays’ front office has been proactive in addressing roster gaps. In addition to signing Ureña and Turnbull, the team moved reliever Erik Swanson to the 60-day injured list on May 5 due to right median nerve entrapment. Swanson, who has a 3.97 ERA across 240 career games, is eligible to return on May 26, potentially adding depth to the bullpen.
General manager Ross Atkins has emphasized the need for external reinforcements. On May 2, he told reporters the team was exploring free-agent options to bolster pitching depth. Internal candidates like Yariel Rodriguez have been considered, but the potential acquisition of a proven starter like Mitch Keller remains a priority. Keller’s 2024 performance, including a 3.88 ERA, makes him an attractive target for a team aiming to contend in the AL East.
The trade market is heating up, with speculation about Scherzer himself as a trade candidate if the Blue Jays fall out of contention by the July deadline. However, the team’s recent performance suggests a focus on competing rather than rebuilding.
Upcoming series against the Rays
The Blue Jays’ three-game series against the Tampa Bay Rays, starting May 13, is a critical opportunity to build on their road trip success. Toronto’s José Berríos, with a 3.38 ERA in 2024, will take the mound in the opener against Tampa Bay’s Shane Baz. Berríos has been a reliable presence, providing stability in a rotation missing Scherzer’s veteran leadership.
The Rays, coming off a 3-3 road trip, present a formidable challenge. Their lineup, led by Yandy Díaz and Brandon Lowe, has been productive, and their pitching staff ranks among the league’s best. The Blue Jays will need to leverage their home-field advantage at Rogers Centre, where they’ve posted a 10-8 record this season.
- Series opener: Berríos vs. Baz on May 13.
- Home performance: 10-8 record at Rogers Centre.
- Rays’ strengths: Strong pitching and consistent offense.
The outcome of this series could shape Toronto’s trajectory in the competitive AL East.
Scherzer’s off-field presence
Even while sidelined, Max Scherzer has made an impact off the field. During a May 3 game against the Cleveland Guardians, he was caught on camera playfully mocking umpire C.B. Bucknor’s calls from the dugout, suggesting the ump was “flipping a coin.” The moment, shared by Jomboy Media on X, showcased Scherzer’s competitive spirit and camaraderie with teammates.
His leadership has been a stabilizing force for a young Blue Jays roster. Scherzer has mentored pitchers like Bowden Francis and Yariel Rodriguez, offering insights from his 18-year career. Manager John Schneider has praised Scherzer’s engagement, noting his ability to connect with players despite his injury.
- Viral moment: Scherzer’s dugout antics against Cleveland.
- Mentorship role: Guiding younger pitchers.
- Schneider’s take: Values Scherzer’s leadership.
Scherzer’s presence, even from the sidelines, remains a valuable asset.
Trade rumors swirl
As Scherzer’s recovery timeline remains uncertain, trade speculation has emerged. On May 10, reports from BVM Sports and Heavy.com suggested the Blue Jays could consider moving Scherzer to a contender like the Seattle Mariners if they fall out of playoff contention. The Mariners, leading the AL West with a 22-14 record, are seeking veteran pitching to complement starters Logan Gilbert and George Kirby.
Toronto’s 17-20 record as of May 9 fueled these discussions, but their recent 4-2 road trip has shifted the narrative. A trade seems unlikely if the Blue Jays remain competitive, especially with Scherzer’s $15.5 million contract expiring at season’s end. The focus remains on his return, with the team hoping he can replicate his 2024 form.
The potential pursuit of Mitch Keller reflects a longer-term strategy. Keller’s youth and contract control make him a valuable asset, but acquiring him would require significant prospect capital.
Pitching depth concerns
The Blue Jays’ rotation woes extend beyond Scherzer. Injuries to key pitchers like Erik Swanson and prospect Jake Bloss, who will undergo UCL surgery, have strained the system. Bloss, a highly rated prospect, was expected to contribute in 2026, but his surgery delays those plans.
Toronto has leaned on unconventional solutions, including using relievers like Eric Lauer in extended roles. Lauer’s performance against Seattle was a bright spot, but the team’s 4.49 ERA among starters underscores the need for stability. The additions of Ureña and Turnbull are stopgap measures, with Turnbull requiring time to ramp up.
- Injury impact: Bloss’s surgery and Swanson’s IL stint.
- Stopgap solutions: Ureña’s debut and Turnbull’s signing.
- Rotation ERA: 4.49, fifth-worst in MLB.
The Blue Jays are navigating a delicate balance as they await Scherzer’s return.
Fan reactions and expectations
Blue Jays fans have expressed a mix of frustration and hope regarding Scherzer’s injury. Social media posts on X highlight the fanbase’s desire for his swift return, with many praising his competitive fire and leadership. Others have voiced concerns about the team’s reliance on a 40-year-old pitcher with a history of injuries.
The sweep of the Mariners sparked renewed optimism, with fans pointing to the team’s offensive potential and bullpen depth. However, the AL East’s competitiveness—led by the Yankees and Red Sox—means every game matters. Scherzer’s return could be a game-changer, but fans are bracing for a cautious timeline.
- Fan sentiment: Hopeful yet cautious about Scherzer.
- Social media buzz: Praise for recent wins.
- AL East outlook: Tight race with New York and Boston.
The fanbase remains engaged, eagerly awaiting updates on their veteran star.
Looking ahead for Toronto
The Blue Jays’ immediate focus is the Tampa Bay series, where strong performances from Berríos and the offense could solidify their standing. Manager John Schneider has emphasized a day-by-day approach, particularly with Scherzer’s recovery. The pitcher is scheduled to throw off a mound soon, with the team monitoring his progress closely.
Longer-term, Toronto’s front office is evaluating its options. The potential trade for Mitch Keller, combined with the development of prospects like Yariel Rodriguez, could reshape the rotation. Scherzer’s return, if successful, would provide a significant boost, but his injury history necessitates contingency plans.
The Blue Jays’ ability to stay competitive in the AL East hinges on their pitching depth and offensive consistency. With Scherzer sidelined, the team is relying on its collective resilience to keep pace in a crowded division.
